Literature DB >> 7294112

Fulminant ocular toxoplasmosis.

R Sabates, R C Pruett, R J Brockhurst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7294112     DOI： 10.1016/0002-9394(81)90642-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  12 in total

1.  Severe bilateral necrotising retinitis caused by Toxoplasma gondii in a patient with systemic lupus erythematosus and diabetes mellitus.

Authors:  J H Yamamoto; D I Boletti; Y Nakashima; C E Hirata; E Olivalves; M M Shinzato; T S Okay; R M Santo; M I S Duarte; J Kalil
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

Review 2.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

3.  Ocular manifestations in congenital toxoplasmosis.

Authors:  Laurent Kodjikian; Martine Wallon; Jacques Fleury; Philippe Denis; Christine Binquet; François Peyron; Justus G Garweg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

4.  Demonstration of Bartonella grahamii DNA in ocular fluids of a patient with neuroretinitis.

Authors:  F T Kerkhoff; A M Bergmans; A van Der Zee; A Rothova
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 5.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

6.  [Diagnosis and treatment of ocular toxoplasmosis : a survey of German-speaking ophthalmologists].

Authors:  N Torun; Z Sherif; J Garweg; U Pleyer
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

Review 7.  Ocular toxoplasmosis in the immunocompromised host.

Authors:  G N Holland
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

Review 8.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

9.  Demonstration of Toxoplasma antigen containing complexes in active toxoplasmosis.

Authors:  F van Knapen; S O Panggabean; J van Leusden
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

10.  Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration.

Authors:  Ryan Rush; Saumil Sheth
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.